patent/SG-172202-A1

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
filingDate	2009-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bf79cad168588fb919d7bb1d65a03a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94a6b5b0b32f1f7a34c9cb44709873ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b35b2621b6663dcd6fa775fbdf24b4f
publicationDate	2011-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	SG-172202-A1
titleOfInvention	Amino pyrazole compound
abstract	The present invention provides amino pyrazole compounds useful in the treatment of chronic myeloproliferative disorders and various cancers, e.g., glioblastoma, breast cancer, multiple myeloma, prostate cancer, and leukemias.
priorityDate	2008-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74561 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409983832

Total number of triples: 20.